« Previous
Next »
Journal of Diabetes and Its Complications
Volume 24, Issue 2
, Pages 102-108
, March 2010
Association of the functional A118G polymorphism of OPRM1 in diabetic patients with foot ulcer pain
References
- . The Diabetic Foot Ulcer Scale (DFS): A quality of life instrument for use in clinical trials. Practical Diabetes International. 2002;19:167–175
- Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: Possible implications for opiate addiction. Proceedings of the National Academy of Sciences of the United States of America. 1998;95:9608–9613
- . Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabetic Medicine. 1998;15:508–514
- . A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care. 1999;22:1036–1042
- . Psychological status of diabetic people with or without lower limb disability. Diabetes Research and Clinical Practice. 1996;32:19–25
- Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty. Acta Anaesthesiologica Scandinavica. 2006;50:787–792
- A genetic association study of the mu opioid receptor and severe opioid dependence. Psychiatric Genetics. 2003;13:169–173
- Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care. 2002;25:113–120
- . Health-related quality of life of patients with diabetes and foot ulcers. Foot & Ankle International. 2005;26:32–37
- Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: Clinical results of a multicentric study of 221 consecutive diabetic subjects. Journal of Internal Medicine. 2002;252:225–232
- The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. Journal of Pain. 2005;6:159–167
- . Pathogenesis and treatment of pain in patients with chronic wounds. Surgical Technology International. 2003;11:168–179
- Prevalence of lower-extremity disease in the US adult population ≥40 years of age with and without diabetes: 1999–2000 national health and nutrition examination survey. Diabetes Care. 2004;27:1591–1597
- . A rapid screening method for a single nucleotide polymorphism (SNP) in the human MOR gene. British Journal of Clinical Pharmacology. 2001;52:711–714
- A genetic association study of the functional A118G polymorphism of the human mu-opioid receptor gene in patients with acute and chronic pain. Anesthesia and Analgesia. 2006;103:1011–1017
- Association of functional opioid receptor genotypes with alcohol dependence in Koreans. Alcoholism, Clinical and Experimental Research. 2004;28:986–990
- . Peripheral neuropathy in patients with diabetic foot ulcers: Clinical and nerve conduction study. Journal of Neurological Sciences. 2007;258:75–79
- . Genetic variability of mu-opioid receptor in an obstetric population. Anesthesiology. 2004;100:1030–1033
- . The human mu-opioid receptor gene polymorphism 118A > G decreases cortical activation in response to specific nociceptive stimulation. Behavioral Neuroscience. 2006;120:1218–1224
- . Symptomatic treatment of painful neuropathy. JAMA. 1998;280:1863–1864
- . Preventive foot care in people with diabetes. Diabetes Care. 2003;26:S78–S79
- Association of micro-opioid receptor gene polymorphism A118G with alcohol dependence in a Japanese population. Neuropsychobiology. 2006;53:137–141
- . A comparison of two diabetic foot ulcer classification systems: The Wagner and the University of Texas wound classification systems. Diabetes Care. 2001;24:84–88
- . Practical treatment of wound pain and trauma: A patient-centered approach. An overview.. Ostomy/Wound Management. 2003;49:2–15
- . The prevalence and occurrence of diabetic foot ulcer pain and its impact on health-related quality of life. Journal of Pain. 2006;7:290–299
- . Living with diabetic foot ulcers: A life of fear, restrictions, and pain. Ostomy/Wound Management. 2004;50:57–67
- Clinical and functional correlates of foot pain in diabetic patients. Disability and Rehabilitation. 1998;20:330–336
- A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia. Anesthesiology. 2008;109:520–526
- . Pain in diabetic foot ulcers. Ostomy/Wound Management. 2003;49:24–29
- . Preventing foot ulcers in patients with diabetes. JAMA. 2005;293:217–228
- . Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations. Neuroreport. 2003;14:569–572
- . Foot problems in diabetes: An overview. Clinical Infectious Diseases. 2004;39:S73–S82
- The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology. 2002;26:106–114
- . A potent and selective endogenous agonist for the mu-opiate receptor. Nature. 1997;386:499–502
PII: S1056-8727(09)00024-5
doi: 10.1016/j.jdiacomp.2009.02.003
© 2010 Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Diabetes and Its Complications
Volume 24, Issue 2
, Pages 102-108
, March 2010
